Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Voluntary Bankruptcy

TheNewsWire August 1, 2023

Tetra Bio-Pharma Cancels New Drug Submission to Health Canada

TheNewsWire May 11, 2023

Tetra Bio-Pharma Announces Health Canada Authorization to Proceed with its Oral ARDS-003 New Drug in Human Trial

TheNewsWire March 10, 2023

Tetra Bio-Pharma Announces Cease Trade Order

TheNewsWire March 7, 2023

IIROC Trading Halt - TBP

Canada NewsWire March 7, 2023

Tetra Bio-Pharma (TSX:TBP) receives millions in government funding for ARDS-003

Trevor Abes  March 3, 2023

Tetra Bio-Pharma Receives Funding from the Government of Canada for ARDS-003

TheNewsWire March 3, 2023

Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements and Related Management's Discussion and Analysis

TheNewsWire March 1, 2023

Tetra Bio-Pharma Announces Listing to OTCPink Market

PR Newswire February 10, 2023

REDUVO(TM) Marketing Approval on the Right Path

PR Newswire December 22, 2022

Tetra Bio-Pharma (TSX:TBP) AI study shows drug efficacy

Caroline Egan  December 6, 2022

Tetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with Favipiravir

PR Newswire December 6, 2022

Tetra Bio-Pharma (TSX:TBP) provides update on patent applications for Novel Therapeutic ARDS-003

John Ballem  November 30, 2022

Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003

PR Newswire November 29, 2022

Tetra (TSX:TBP) updates on new THC-based drug

Caroline Egan  November 18, 2022

Tetra Bio-Pharma Provides Update on Its REDUVO(TM) New Drug Submission

Canada NewsWire November 18, 2022

Tetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue Ocean

PR Newswire October 27, 2022

Tetra (TSX:TBP) and partner apply for US$750K funding

Caroline Egan  October 11, 2022

Tetra and Prepaire Jointly Apply to BARDA for Funding

PR Newswire October 11, 2022

Tetra Bio-Pharma (TSX:TBP) increases financing deal

Caroline Egan  September 8, 2022